Short description: Chemical compound
EHNA |
| Identifiers |
|---|
IUPAC name
3-(6-aminopurin-9-yl)nonan-2-ol
|
| CAS Number | |
|---|
| PubChem CID | |
|---|
| ChemSpider | |
|---|
| ChEMBL | - ChEMBL50378
Y
|
|---|
| Chemical and physical data |
|---|
| Formula | C14H23N5O |
|---|
| Molar mass | 277.372 g·mol−1 |
|---|
| 3D model (JSmol) | |
|---|
SMILES
CCCCCCC(C(C)O)n1cnc2c1ncnc2N
|
InChI
InChI=1S/C14H23N5O/c1-3-4-5-6-7-11(10(2)20)19-9-18-12-13(15)16-8-17-14(12)19/h8-11,20H,3-7H2,1-2H3,(H2,15,16,17) Key:IOSAAWHGJUZBOG-UHFFFAOYSA-N
|
| (verify) |
EHNA (erythro-9-(2-hydroxy-3-nonly)adenine) is a potent adenosine deaminase inhibitor,[1] which also acts as a phosphodiesterase inhibitor that selectively inhibits phosphodiesterase type 2 (PDE2).[2][3]
References
- ↑ "Sigma Aldrich". http://www.sigmaaldrich.com/catalog/product/sigma/e114?lang=en®ion=US.
- ↑ "Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine". Cellular Signalling 7 (7): 733–8. September 1995. doi:10.1016/0898-6568(95)00042-N. PMID 8519602.
- ↑ "Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes". Molecular Pharmacology 48 (1): 121–30. July 1995. PMID 7623766.
 | Original source: https://en.wikipedia.org/wiki/EHNA. Read more |